| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |